A facility dedicated to Phase 1–4 clinical trials that scientifically and ethically supports clinical research for new drug development and the establishment of novel therapies.

We provide an optimal research environment for developing new cancer drugs and establishing innovative therapies. We have built a customized, all-phase support system spanning FIH (First-in-Human) and Phase 1 studies through large-scale Phase 3 trials.

As Korea's only dedicated pediatric outpatient clinical research facility, it provides a safe research environment specialized for pediatric participants.

Pediatric Clinical Trial Unit
Function
  • As Korea's only dedicated pediatric outpatient clinical research facility, administers investigational products to pediatric participants and monitors adverse reactions
  • Collection, processing, and storage of research specimens
Facilities (space) & equipment
  • Comprises a total of 3 beds
  • Centrifuge
  • Refrigerator and low-temperature/ultra-low-temperature freezers

We provide consistent consultation across all stages — planning, conduct, and results reporting — of clinical research, including new drug development clinical trials.

Pharmacokinetics Laboratory
Function
  • Provides consistent consultation from the planning stage through conduct and results reporting for various clinical studies, including new drug development clinical trials
  • Provides independent consultation in coordination with the Pharmaceutical Research Laboratory and the PMS & Multicenter Research Support Office